MichaelBaramMD

Pulmonology • Philadelphia, PA

Critical Care Medicine, Pleural Disease

Associate Professor, Medicine, Jefferson Medical College-Thos Jefferson Univ

Join to view full profile

Dr. Baram is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Baram's full profile

Already have an account?

Office
834 Walnut Street Suite 650
Philadelphia, PA 19107
Phone+1 215-955-6591

Fax+1 215-955-0830

Education & Training

Brown UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
Christiana Care Health ServicesResidency, Internal Medicine/Emergency Medicine, 1997 - 2002
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997

Certifications & Licensure

PA State Medical License 2006 - 2026
DE State Medical License 1999 - 2009
RI State Medical License 2003 - 2006
MA State Medical License 2003 - 2004
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Convalescent Plasma for the Treatment of COVID-19 Start of enrollment: 2020 Apr 15
Completed
Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS Start of enrollment: 2021 Jun 29
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15
Completed
Phase 2, Phase 3
Roles: Contact

Publications & Presentations

PubMed

The Discover In-Hospital Cardiac Arrest (Discover IHCA) Study: An Investigation of Hospital Practices After In-Hospital Cardiac Arrest.
Luke Andrea, Nathaniel S Herman, Jacob Vine, Katherine M Berg, Saiara Choudhury
Critical Care Explorations. 2024-09-01
Observational study of the effect of ketamine infusions on sedation depth, inflammation, and clinical outcomes in mechanically ventilated patients with SARS-CoV-2.
David Wyler, Marc C Torjman, Ron Leong, Michael Baram, William Denk
Anaesthesia and Intensive Care. 2024-03-01
1 citations
Design and rationale of the CHILL phase II trial of hypothermia and neuromuscular blockade for acute respiratory distress syndrome.
Carl B Shanholtz, Michael L Terrin, Thelma Harrington, Caleb Chan, Whittney Warren
Contemporary Clinical Trials Communications. 2023-06-01

Press Mentions

COVID-19 Trials Opening at Accelerated RateMay 5th, 2020
Biohaven Receives FDA May Proceed Letter to Begin Phase 2 Trial of Intranasal Vazegepant to Treat Lung Inflammation After COVID-19 InfectionApril 9th, 2020